Superagonistic Fluorinated Vitamin D3 Analogs Stabilize Helix 12 of the Vitamin D Receptor

被引:38
作者
Eelen, Guy [1 ]
Valle, Noelia [2 ]
Sato, Yoshiteru [3 ]
Rochel, Natacha [3 ]
Verlinden, Lieve [1 ]
De Clercq, Pierre [4 ]
Moras, Dino [3 ]
Bouillon, Roger [1 ]
Munoz, Alberto [2 ]
Verstuyf, Annemieke [1 ]
机构
[1] Katholieke Univ Leuven, LEGENDO, B-3000 Louvain, Belgium
[2] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, E-28029 Madrid, Spain
[3] Dept Biol & Genom Struct, IGBMC, F-67400 Illkirch Graffenstaden, France
[4] Univ Ghent, Vakgroep Organ Chem, B-9000 Ghent, Belgium
来源
CHEMISTRY & BIOLOGY | 2008年 / 15卷 / 10期
关键词
D O I
10.1016/j.chembiol.2008.08.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Side chain fluorination is often used to make analogs of 1,25-dihydroxyvitamin D-3 [1,25(OH)(2)D-3] resistant to degradation by 24-hydroxylase. The fluorinated nonsteroidal analogs CD578, WU515, and WY1113 have an increased prodifferentiating action on SW480-ADH colon cancer cells, which correlated with stronger induction of vitamin D receptor (VDR)-coactivator interactions and stronger repression of beta-catenin/TCF activity. Cocrystallization of analog CD578 with the zebrafish (z)VDR and an SRC-1 coactivator peptide showed that the fluorine atoms of CD578 make additional contacts with Va1444 and Phe448 of activation helix 12 (H12) of the zVDR and with Leu440 of the H11-H12 loop. Consequently, the SRC-1 peptide makes more contacts with the VDR-CD578 complex than with the VDR-1,25(OH)(2)D-3 Complex. These data show that fluorination not only affects degradation of an analog but can also have direct effects on H12 stabilization.
引用
收藏
页码:1029 / 1034
页数:6
相关论文
共 50 条
[21]   Synthesis and vitamin D receptor affinity of 16-oxa vitamin D3 analogues [J].
Ibe, Kouta ;
Yamada, Takeshi ;
Okamoto, Sentaro .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2019, 17 (48) :10188-10200
[22]   Hypercalcemia caused by vitamin D3 analogs in psoriasis treatment [J].
Braun, Gerald S. ;
Witt, Matthias ;
Mayer, Verena ;
Schmid, Holger .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2007, 46 (12) :1315-1317
[23]   C-20 cyclopropyl vitamin D3 analogs [J].
Uskokovic, Milan R. ;
Manchand, Percy ;
Marczak, Stanislaw ;
Maehr, Hubert ;
Jankowski, Pawel ;
Adorini, Luciano ;
Reddy, G. Satyanarayana .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (12) :1289-1296
[24]   An evaluation of the biologic activity and vitamin D receptor binding affinity of the photoisomers of vitamin D3, previtamin D3 and their hydroxylated derivatives [J].
Chen, TC ;
Persons, KS ;
Lu, ZR ;
Mathieu, JS ;
Holick, MF .
BIOLOGIC EFFECTS OF LIGHT 1998, 1999, :145-148
[25]   Activity of various hydroxylated vitamin D3 analogs for improving phosphorus utilisation in chicks receiving diets adequate in vitamin D3 [J].
Biehl, RR ;
Baker, DH ;
Deluca, HF .
BRITISH POULTRY SCIENCE, 1998, 39 (03) :408-412
[26]   Bioequivalence of alendronate and vitamin D3 in an alendronate/vitamin D3 combination tablet [J].
Yeh, Geng-Chang ;
Brown, Kevin ;
Mols, Ramon ;
Woolf, Eric ;
Wright, Hamish ;
Maganti, Lata ;
Zajic, Stefan .
FASEB JOURNAL, 2014, 28 (01)
[27]   Bioavailability of Alendronate and Vitamin D3 in an Alendronate/Vitamin D3 Combination Tablet [J].
Denker, Andrew E. ;
Lazarus, Nicole ;
Porras, Arturo ;
Ramakrishnan, Rohini ;
Constanzer, Marvin ;
Scott, Boyd B. ;
Chavez-Eng, Cynthia ;
Woolf, Eric ;
Maganti, Lata ;
Larson, Patrick ;
Gottesdiener, Keith ;
Wagner, John A. .
JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (10) :1439-1448
[28]   Polymorphism of the vitamin D3 receptor in patients with psoriasis [J].
Hiroshi Okita ;
Tsutomu Ohtsuka ;
Akio Yamakage ;
Soji Yamazaki .
Archives of Dermatological Research, 2002, 294 :159-162
[29]   Expression of vitamin D3 receptor in kidney tumors [J].
Liu, Wenhua ;
Tretiakova, Maria ;
Kong, Juan ;
Turkyilmaz, Muge ;
Li, Yan Chun ;
Krausz, Thomas .
HUMAN PATHOLOGY, 2006, 37 (10) :1268-1278
[30]   A role of helix 12 of the vitamin D receptor in SMRT corepressor interaction [J].
Kim, Ji Young ;
Son, You Lee ;
Lee, Young Chul .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 379 (03) :780-784